This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kanaph Therapeutics Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jinhwan Kim - Innovator in Pharmaceutical Research
Introduction
Jinhwan Kim is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments.
Latest Patents
Jinhwan Kim holds a patent for an SHP2 inhibitor and its use. The present invention relates to an inhibitor of SHP2, a pharmaceutical composition for preventing or treating diseases related to SHP2, and a method for treating and preventing such diseases. This invention can effectively prevent or treat diseases associated with SHP2.
Career Highlights
Jinhwan Kim is currently employed at Kanaph Therapeutics Inc., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Some of his coworkers include Miyeon Kim and Dohyun Park, who contribute to the innovative environment at Kanaph Therapeutics Inc.
Conclusion
Jinhwan Kim's work in developing SHP2 inhibitors showcases his commitment to advancing medical science and improving patient outcomes. His contributions are vital in the ongoing quest for effective treatments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile